Over 13,000 Blood Pressure Medication Bottles Recalled Nationwide in US
Indian pharmaceutical company Inventia Healthcare Limited has initiated a nationwide recall of over 13,000 bottles of its blood pressure medication in the United States. The recall is due to the potential for the drug to be ineffective.
Inventia Healthcare Limited, an India-based pharmaceutical company, has initiated a voluntary nationwide recall affecting more than 13,000 bottles of its chlorthalidone-based blood pressure medication in the United States. The U.S. Food and Drug Administration (FDA) later posted an enforcement report categorizing the recall as Class II, signifying that the use of the product may cause temporary or medically reversible adverse health consequences.
The reason cited for the recall is "Failed Dissolution Specifications." According to the FDA, chlorthalidone tablets must dissolve in the body to be effective, and if they do not, the medication may not perform as intended, potentially leading to suboptimal blood pressure control.
The recall specifically pertains to Chlorthalidone Tablets, USP, 25 mg, packaged in bottles of 100 tablets. The affected product was manufactured by Inventia Healthcare Limited and has been distributed nationwide across the U.S. The FDA's report does not specify which pharmacies or distributors received the medication.
Consumers who have the recalled medication are advised by health information sources to contact their doctor or pharmacist before making any changes to their current medication regimen. The FDA's enforcement notice did not provide specific instructions for consumers regarding actions to take.